Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly

Pituitary(2020)10.1007/s11102-020-01094-4Source: DataRank Database

Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly is a research paper published in Pituitary (2020). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.56)OA: greenTopics (61)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Jeffrey N. Bruce ORCID,Carlos Reyes-Vidal,Simran Singh,Yessica DeLeon,Zhezhen Jin ORCID

Live enrichment

PubMed:33124000 PMC:PMC7969360 OpenAlex:https://openalex.org/W3096877786

National Institutes of Health

Grant: DK110771

National Institutes of Health

Grant: DK064720

National Center for Advancing Translational Sciences

Grant: UL1 TR000040

NIDDK NIH HHS

Grant: R01 DK110771

NCRR NIH HHS

Grant: UL1 RR024156

NCATS NIH HHS

Grant: UL1 TR001873

NIDDK NIH HHS

Grant: R01 DK064720

NIDDK NIH HHS

Grant: R56 DK064720

National Institutes of Health

Grant: 5R01DK110771-04

New Approaches to the Evaluation and Treatment of Acromegaly

National Institutes of Health

Grant: 8UL1TR000040-07

Clinical and Translational Science Award

National Institutes of Health

Grant: 5R01DK064720-10

New Approaches to the Evaluation and Treatment of Acromegaly

FWCI

1.56

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Springer TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7969360

publisherhttps://link.springer.com/content/pdf/10.1007/s11102-020-01094-4.pdf

publisherhttps://link.springer.com/article/10.1007/s11102-020-01094-4/fulltext.html

journalhttps://doi.org/10.1007/s11102-020-01094-4

Fields of Study

Pituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsAdrenal and Paraganglionic Tumors03 medical and health sciences0302 clinical medicineAcromegalyAdultAgedFemaleGlucose Tolerance TestHuman Growth HormoneHumansInsulin ResistanceInsulin-Like Growth Factor IMaleMiddle AgedPrognosisProspective StudiesYoung Adult

MeSH Terms

AcromegalyAdultAgedFemaleGlucose Tolerance TestHumansInsulin ResistanceInsulin-Like Growth Factor IMaleMiddle AgedPrognosisProspective StudiesHuman Growth HormoneYoung Adult

Keywords

AcromegalyMedicineInternal medicineNadirEndocrinologyPercentileTranssphenoidal surgeryGrowth hormoneGastroenterologySurgeryHormoneAdenomaPituitary adenomaIGF-1GHAdultMaleHuman Growth HormoneGlucose Tolerance TestMiddle AgedPrognosisYoung AdultHumansFemaleProspective StudiesInsulin ResistanceInsulin-Like Growth Factor IAged

Sustainable Development Goals

SDG 0: Good health and well-being